drugset / Trial / NCT03027154

Summary

In this clinical research,48 cases TB (Tuberculosis patients) participants and 48 cases non-TB participants with lung disease who all meet the standard are divided into different groups through a randomized and blind method. Every subject inject intradermally ESAT6-CFP10 and TB-PPD (tuberculin purified protein derivative) in different arms of the same person by blind method. Specific gama-interferon (γ-IFN) detection is needed before the injection.Measure the induration and (or) redness of longitudinal diameter size and transverse diameter vernier caliper by vernier caliper after injection 24h, 48h and 72h. At the same time, we observe all kind of adverse events in order to assess the safety of drug.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ESAT6-CFP10 Protein / enzyme biologic 10 ug/ml Other
Subject TB-PPD Diagnostic / imaging agent Other

Indications